Načítá se...
High dose chemotherapy with stem cell support in the treatment of testicular cancer
Testicular germ cell cancer (TGCC) is rare form of malignant disease that occurs mostly in young man between age 15 and 40. The worldwide incidence of TGCC is 1.5 per 100000 man with the highest rates in North Europe. After discovery of cisplatin cure rates of TGCC are very favorable between 90%-95%...
Uloženo v:
| Vydáno v: | World J Stem Cells |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Baishideng Publishing Group Inc
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4691691/ https://ncbi.nlm.nih.gov/pubmed/26730267 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4252/wjsc.v7.i11.1222 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|